UCSF Urology Clinicians Present Research Findings at SurgeWest 2025
Development of a novel RNA biomarker for prostate cancer detection using seminal fluid and mismatched opioid prescriptions following urologic surgery are among the topics being presented by UCSF clinicians and researchers at the Western Section of the American Urological Association’s SurgeWest 2025. The 101st SurgeWest meeting, taking place from Nov. 2-6, in Napa, California, is the largest regional gathering of urology professionals in the Western U.S.